#pharmaceutical-ai News & Analysis

4 articles tagged with #pharmaceutical-ai. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

4 articles

AIBullishBlockonomi · Apr 177/10

🧠

OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration

OpenAI has launched GPT-Rosalind, an AI model designed to accelerate pharmaceutical drug discovery, partnering with major life sciences companies including Amgen, Moderna, and Thermo Fisher. The model represents a significant application of advanced AI technology beyond traditional software domains, with potential to compress drug development timelines and reduce research costs.

🏢 OpenAI

AIBullisharXiv – CS AI · May 76/10

🧠

Curated AI beats frontier LLMs at pharma asset discovery

Gosset, a curated AI platform for pharmaceutical asset discovery, outperforms leading frontier LLMs (Claude, GPT-5.5, Gemini, Perplexity) by 3.2x on drug discovery queries, achieving perfect precision and complete recall on niche oncology and immunology targets. The research demonstrates that specialized, annotated databases significantly outperform general-purpose models with web search for domain-specific tasks.

🏢 Perplexity🧠 GPT-5🧠 Claude

AIBullishcrypto.news · Apr 146/10

🧠

Senhwa Biosciences inks up to $16M funding deal with GEM to boost AI drug discovery

Taiwanese biopharmaceutical company Senhwa Biosciences has secured up to $16 million in funding from GEM through a memorandum of understanding to accelerate AI-driven drug discovery. This partnership represents growing institutional investment in combining artificial intelligence with pharmaceutical development to expedite clinical-stage research.

AIBullisharXiv – CS AI · Mar 36/106

🧠

GlassMol: Interpretable Molecular Property Prediction with Concept Bottleneck Models

Researchers introduce GlassMol, a new interpretable AI model for molecular property prediction that addresses the black-box problem in drug discovery. The model uses Concept Bottleneck Models with automated concept curation and LLM-guided selection, achieving performance that matches or exceeds traditional black-box models across thirteen benchmarks.